Further experimental studies have shown that mice deficient in Lamtor5 in myeloid cells develop SLE-like pathologies, and Lamtor5-deficient macrophages exhibit a hyperresponsive phenotype resulting from uncontrolled activation of the mTORC1 pathway. Here, LAMTOR5 is linked to systemic lupus erythematosus.